Author:
De Wals Philippe,Desjardins Michaël
Reference30 articles.
1. Public Health Agency of Canada. Canadian Immunization Guide. 2022. Available at: https://www.canada.ca/en/public-health/services/canadian-immunization-guide.html.
2. Rubin LG, Levin MJ, Ljungman P, Davies EG, Avery R, Tomblyn M, et al. 2013. IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis. 2014;58(3):309-18. doi: 10.1093/cid/cit816. Erratum in: Clin Infect Dis. 2014 Jul 1;59(1):144.
3. Kobayashi M, Pilishvili T, Farrar JL, Leidner AJ, Gierke R, Prasad N, et al. Pneumococcal vaccine for adults aged ≥19 years: Recommendations of the Advisory Committee on Immunization Practices, United States, 2023. MMWR Recomm Rep 2023;72(No. RR-3):1–39. doi:http://dx.doi.org/10.15585/mmwr.rr7203a1.
4. UK health Security Agency. The Green book. Chapter 5: Pneumococcal. 27 July 2023. Available at: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1178054/Green_Book_Chapter_25_Pneumococcal_27_7_23.pdf.
5. Sequential administration of Prevnar 13™ and PNEUMOVAX™ 23 in healthy participants 50 years of age and older;Buchwald;Hum Vaccin Immunother,2021